BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8232506)

  • 1. Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up.
    Andersen JW; Smalley RV
    N Engl J Med; 1993 Dec; 329(24):1821-2. PubMed ID: 8232506
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV; Andersen JW; Hawkins MJ; Bhide V; O'Connell MJ; Oken MM; Borden EC
    N Engl J Med; 1992 Nov; 327(19):1336-41. PubMed ID: 1406835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Salloum E; Levin M
    N Engl J Med; 1993 Aug; 329(8):581; author reply 581-2. PubMed ID: 8336764
    [No Abstract]   [Full Text] [Related]  

  • 5. New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):32-5. PubMed ID: 8073307
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Decaudin D
    N Engl J Med; 1998 Nov; 339(20):1477. PubMed ID: 9841321
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Kosmas C; Malamos NA; Antonopoulos MJ
    N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841319
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of malignant non-Hodgkin's lymphoma in elderly patients.
    Michiels JJ
    Neth J Med; 1988 Feb; 32(1-2):50-1. PubMed ID: 3347326
    [No Abstract]   [Full Text] [Related]  

  • 9. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Mross K
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637757
    [No Abstract]   [Full Text] [Related]  

  • 11. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
    Basaran G; Basaran M; Onat H
    J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Machida U; Kami M; Hirai H
    N Engl J Med; 1998 Nov; 339(20):1475-6; author reply 1477. PubMed ID: 9841318
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoradiotherapy for localized non-Hodgkin's lymphoma.
    Cosset JM
    N Engl J Med; 1998 Jul; 339(1):44-5. PubMed ID: 9647881
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Mounier N; Gisselbrecht C; Lepage E
    N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841320
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
    Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A
    Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516
    [No Abstract]   [Full Text] [Related]  

  • 19. Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma.
    Meyer RM; Quirt IC; Skillings JR; Cripps MC; Bramwell VH; Weinerman BH; Gospodarowicz MK; Burns BF; Sargeant AM; Shepherd LE
    N Engl J Med; 1993 Dec; 329(24):1770-6. PubMed ID: 7694148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.